... phase II and translational study of cetuximab in metastatic colorectalcarcinoma refractory to irinotecan, oxaliplatin, and fluoropyrimidines. J Clin Oncol 24, 4914–4921.3 Khambata-Ford S, Garrett ... Inoue A, Hagiwara K, Sunaga N,Yanagitani N, Hida T et al. (2009) Combined SurvivalAnalysis of Prospective Clinical Trials of Gefitinib for Non-Small Cell Lung Cancer with EGFR Mutations.Clin ... with adenocarcinoma than in those with other histological subtypes of cancer, and in indi-viduals who have never smoked than in those with a his-tory of smoking [10]. These clinical observations...